WILMINGTON, N.C. (WECT) - Indochine announced in a Facebook post that its owner and founder died. According to the post, the restaurant’s owner, Solange “Niki” Thompson, died Thursday, Dec. 18, ...
Niki Prongos is a twitchy, fluid mover with a quick trigger in pass protection and above-average movement skills that offer upside to develop into a future starter, but below-average play strength and ...
A 27-story tower is under construction near Arizona State University in downtown Tempe, and it will become the city's second-tallest. The tower is part of a mixed-use project, called Astria Tempe, ...
Paris and Nicky Hilton are socialite royalty. The two sisters took over the fashion and party club scene in the early aughts. They have remained close all their lives and now hang out with their kids.
Astria Therapeutics, Inc. (ATXS) came out with a quarterly loss of $0.55 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to a loss of $0.42 per share a year ago. These ...
EXCLUSIVE: Actor and producer Nicholas G. Sims has signed with Asteria Artists for management. Sims will appear in the upcoming third season of Starz’s acclaimed drama P-Valley, the series created by ...
Los Angeles Dodgers pitcher Yoshinobu Yamamoto has become one of baseball’s biggest stars — and fans are now just as curious about his life off the field. In November 2024, dating rumors began ...
Oscar-winning directors Michael Govier and Will McCormack are behind the project, with the team planning an awards campaign. By Borys Kit Senior Film Writer Star Wars Shake-Up: Kathleen Kennedy Steps ...
Shares of Astria Therapeutics ATXS rallied 37.1% on Tuesday after the company signed a definitive agreement to be acquired by BioCryst Pharmaceuticals BCRX for a mix of cash and stock, representing an ...
BioCryst Pharmaceuticals (NASDAQ:BCRX) has agreed to acquire biopharmaceutical firm Astria Therapeutics (NASDAQ:ATXS) for a mix of cash and stock representing an implied value of $13.00 per Astria ...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) on Tuesday agreed to acquire Astria Therapeutics, Inc. (NASDAQ:ATXS) for a mix of cash and stock. The deal represents an implied value of $13 per Astria ...